Ireland's Cannabis Risk Assessment: What the 2023 Assembly Recommended

September 12, 2026

Photo via Pexels.

Somewhere in the past year, the phrase "Cannabis Risk Assessment Group" started circulating in Irish cannabis coverage as though it were a functioning government body with a mandate, a chair, and a timeline. It isn't -- or at least, nothing in the public record confirms that it is. What actually exists is a paper trail: a Citizens' Assembly that met for seven months in 2023, an Oireachtas committee that spent 2024 picking through that Assembly's recommendations, and a Department of Health that in 2026 is reviewing one narrow piece of the puzzle -- medical access -- while synthetic cannabinoids get their own separate, more urgent working group.

This piece pulls those threads apart. It covers what the Assembly actually voted on and by what margin, what the Joint Committee on Drugs Use added on top of that in its interim response, and what is verifiably active right now, in 2026, versus what's still a proposal sitting in a report nobody in government is obliged to act on. If you've seen the Cannabis Risk Assessment Group referenced as though it's already reviewing applications or setting policy, treat that with real skepticism until there's a named ministerial order or Oireachtas record establishing it.

Inside the 2023 Citizens' Assembly on Drugs Use

Photo via Pexels.

The Citizens' Assembly on Drugs Use ran from April to October 2023, one of a series of these deliberative bodies Ireland has used in recent years to work through issues the Oireachtas finds politically awkward to touch first -- abortion and marriage equality being the earlier, higher-profile examples. Membership fluctuated across sessions, somewhere between 87 and 99 people drawn from the public via random selection designed to mirror the country's demographics, plus an independent chair. For drugs, that chair was Paul Reid, who'd previously run the Health Service Executive through the pandemic, giving him a working familiarity with how health systems buckle under demand they weren't built for.

Over its sitting weekends, the Assembly took evidence from addiction clinicians, An Garda Síochána, international drug policy researchers, and -- critically -- people who'd used drugs or lost family members to overdose. That lived-experience testimony carried real weight in the room, according to accounts from members afterward. It's a different input mix than a normal legislative committee gets, and it shows in the final output: 36 recommendations spanning legislative change, policy reform, and operational fixes to services, all aimed at treating drug use primarily as a health issue rather than a purely criminal one.

The final report landed in January 2024, split across two volumes -- one laying out the recommendations themselves, the other documenting the evidence base and vote breakdowns behind them. Reid characterized the outcome plainly: the Assembly had backed a pivot toward a comprehensive, health-led response to drug use generally, including decriminalisation of personal possession. That much passed with reasonably clear support. Cannabis specifically was a messier story, and it's worth walking through separately because the margin there was almost nothing.

The 39-38 vote that decided against legalisation

In the first-round vote, a majority of Citizens' Assembly members (36 of 69) backed legalisation and regulation of cannabis, followed by 23 favouring a health-led strategy, while only 10 supported maintaining the status quo.

Here's where the numbers actually matter. When members were asked how Ireland should treat cannabis specifically, they didn't converge on one answer -- they split three distinct ways. Thirty-six members backed full legalisation and regulation, treating cannabis roughly the way alcohol is treated: legal, licensed, taxed. Twenty-three backed a comprehensive health-led strategy that would stop short of legalisation but move decisively away from criminalisation. Ten wanted to keep the status quo largely intact. No option had a majority on that first pass.

What happened next is the detail that gets lost when people summarize the Assembly as having simply chosen a health-led approach. On the final ballot, once the field narrowed to a straight choice, it came down to 39 votes for the health-led strategy versus 38 for legalisation and regulation. One vote. That's not a mandate in any meaningful sense -- it's a coin flip that happened to land on one side.

Members and observers who followed the sessions closely point to a specific intervention as having plausibly tipped that single vote: shortly before the final meeting, the Irish College of General Practitioners made its position known, arguing that legalisation would carry real dangers and shouldn't be the Assembly's recommendation. GPs carry a particular kind of institutional credibility on health questions, and for an assembly of ordinary citizens weighing a genuinely difficult tradeoff, a late, clearly stated clinical objection from a respected professional body is exactly the kind of thing that could move a handful of still-undecided members in the final days.

The upshot is that Ireland's Citizens' Assembly came within one vote of recommending legalisation and didn't get there -- a notably different outcome from comparable citizens' assemblies in other jurisdictions that have landed more decisively on one side or the other. It's a result worth sitting with rather than rounding off, because the government response since has been shaped by exactly how narrow that margin was.

What the Oireachtas committee added in 2024

The Assembly's report didn't become policy on its own -- it went to the Oireachtas, which set up the Joint Committee on Drugs Use to go through all 36 recommendations line by line. That committee's early work included an interim report that leaned toward decriminalisation as a direction of travel, and it was given a deadline of January 2025 to produce a reasoned response to each of the 36 items -- meaning either an endorsement, a modification, or an explanation of why a given recommendation wasn't being taken forward.

On cannabis, the committee went further than the Assembly's narrow vote might have suggested it would. It floated a limited, not-for-profit cannabis legalisation model built around cannabis social clubs -- small, membership-based cultivation and distribution structures rather than a commercial retail market -- explicitly pointing to Spain's long-running club scene and Germany's 2024 reforms as reference points worth studying. It also recommended repealing Section 3 of the Misuse of Drugs Act 1997, the provision that criminalises personal possession, which would amount to full decriminalisation rather than the more cautious health-led framing the Assembly's final vote had landed on.

That's a meaningful gap worth flagging: the committee's recommendations on cannabis clubs and full decriminalisation go noticeably further than what the Citizens' Assembly's own cannabis-specific vote actually supported. It's the committee's judgment layered on top of the Assembly's input, not a straight pass-through of it.

None of it is binding. An industry source speaking to Business of Cannabis put it bluntly: there's no legal obligation on the Government to implement anything from either the Assembly's report or the committee's response to it. Both are advisory inputs into a political process that the Government controls entirely, and it can accept, ignore, or partially adopt any piece of either document at its own pace.

So what's actually operating in 2026?

Photo by Jeff W via Unsplash.

So what's actually running right now, in 2026? Start with the thing that seems to be causing the most confusion: no source confirms an independently operating body called the Cannabis Risk Assessment Group. If it exists as a formal structure with staff, a chair, and a mandate, it hasn't been documented in any ministerial announcement or Oireachtas record available at time of writing. The honest framing is that it's a proposed or discussed structure -- not a live agency currently doing risk assessment work. Anyone citing it as an active decision-making body should be asked for a source.

What is confirmed and active is narrower and more specific: the Medical Cannabis Access Programme, MCAP, is under formal review, chaired by Professor Shane Allwright, who was appointed to that role in April 2026. MCAP has existed since 2021 as Ireland's structured route for patients to access cannabis-based products for a small number of specified conditions, prescribed through consultant referral. A written ministerial answer delivered to the Oireachtas on March 18, 2026, disclosed that fewer than 100 patients have been approved under the programme since it launched five years earlier -- a number that's drawn sustained criticism from patient advocates as evidence the scheme's eligibility criteria and prescriber pathway are too restrictive to function as intended.

Separately, a joint working group has been convened specifically to address synthetic cannabinoids -- lab-produced compounds sold as cannabis substitutes that carry a distinct and, by most clinical accounts, more urgent risk profile than herbal cannabis itself. This is a different track from the MCAP review and from the broader Citizens' Assembly follow-through, driven by enforcement and public health concerns rather than access policy.

Given how much is still in motion, the responsible move for readers is to treat this whole area as unsettled and check directly with the Department of Health or Oireachtas records for the current status before relying on any secondhand summary -- this one included.

Why so little has moved since the vote

Photo via Unsplash.

The pattern underneath all of this is straightforward once you see it: both the Citizens' Assembly and the Joint Committee on Drugs Use produce advisory outputs, and the Government retains complete discretion over what, if anything, becomes law. Neither body can compel legislative action. That's true of every Irish citizens' assembly to date, and it's exactly why the marriage equality and abortion assemblies needed subsequent referendums to actually change anything -- deliberation informs, it doesn't legislate.

Concretely, that means the Misuse of Drugs Act 1997 remains fully in force today, Section 3 included, meaning personal possession of cannabis is still a criminal offence in Ireland regardless of what the Oireachtas committee recommended about repealing it. Nothing in either report changed the law on the ground.

The 39-38 vote is doing a lot of quiet political work here. A one-vote margin on the cannabis question gives the Government real cover to move slowly, because there's no clear public mandate to point to in either direction -- not for legalisation, not decisively for the health-led alternative that narrowly won. When a Citizens' Assembly is nearly split down the middle, ministers can reasonably argue that further legislative caution is warranted, and that's essentially been the posture since January 2024.

MCAP's numbers feed the same argument from the other direction. Advocates point to fewer than 100 approved patients in five years as proof that the current health-led, tightly controlled access model doesn't actually deliver much in practice, whatever its intentions. It's a useful contrast against jurisdictions the Oireachtas committee itself cited as templates: Germany moved to a partial legalisation model in 2024 allowing home cultivation and cannabis clubs, and Malta established a not-for-profit cannabis club system back in 2021. Both are now years into implementation. Ireland, by comparison, is still at the stage of commissioning reviews and awaiting ministerial responses to a report that's over two years old.

If you want to know whether Ireland is actually moving on cannabis policy, watch two things and largely ignore the rest. First, the Allwright review of MCAP -- when it reports, and whether it recommends widening eligibility or restructuring the prescriber pathway, will tell you more about the government's real appetite for reform than any citizens' assembly report ever will, because it's the one process currently active with a named chair and a defined scope. Second, watch for an actual formal government response to the 36 Citizens' Assembly recommendations as a full set, not piecemeal leaks or committee interim statements -- that response, whenever it lands, is the document that will show which of the 36 items survive contact with government and which quietly don't.

Everything else, including any group name circulating without a confirmed statutory basis or ministerial order behind it, is noise until proven otherwise. Ireland's drug policy debate has real substance -- a nearly-tied citizens' vote, a committee willing to recommend more than that vote supported, and a medical access programme that by its own numbers is barely reaching anyone. That's plenty to track without inventing agencies that aren't yet confirmed to exist.